Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

Psychiatrist claims medical marijuana dangerous for treatment of psychiatric problems

Using medical marijuana to treat conditions such as anxiety and depression is dangerous and has no basis in medical science, says Dr. Timothy R. Jennings, a prominent Tennessee psychiatrist and consultant to The Center for Counseling and Health Resources in Edmonds, WA.

22 Jan 2013

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

Honeybee silk-inspired materials; a deconstruction of the Ebola virus; how microbes evolve resistance to antibiotics; and a possible connection between Alzheimer's disease and type II diabetes are just some of the intriguing topics that will be presented at the 57th Annual Meeting of the Biophysical Society (BPS).

22 Jan 2013

Dopamine synthesis increased in patients at high risk for psychosis

UK study results show that patients at ultra-high risk for psychosis have elevated dopamine synthesis capacity in the dorsal striatum.

17 Jan 2013

MPAs may reflect genetic risk for schizophrenia

Minor physical anomalies are more common in schizophrenia patients and their unaffected siblings than in mentally healthy individuals without a family history of the disorder, research shows.

16 Jan 2013

Fifteen established scientists to receive NARSAD Distinguished Investigator Grants

The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) announced the latest recipients of its highly competitive NARSAD Distinguished Investigator Grants.

16 Jan 2013

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

16 Jan 2013

Vanderbilt University, AstraZeneca partner to identify candidate drugs for major brain diseases

Today, AstraZeneca and Vanderbilt University announced they have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer's disease and schizophrenia.

16 Jan 2013

Patients with Parkinson's develop artistic talents after dopamine-inducing therapy

Parkinson's experts across the world have been reporting a remarkable phenomenon - many patients treated with drugs to increase the activity of dopamine in the brain as a therapy for motor symptoms such as tremors and muscle rigidity are developing new creative talents, including painting, sculpting, writing, and more.

16 Jan 2013

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).

16 Jan 2013

Cancer risk not increased in schizophrenia, bipolar disorder

Results from a large UK study suggest that people with severe mental illness are not at increased risk for developing common cancers.

14 Jan 2013

Factors linked to self-harm in early psychosis identified

A meta-analysis of published studies has identified factors associated with deliberate self-harm before and after treatment in patients with first-episode psychosis.

14 Jan 2013

Virtual patient can help future physicians more comfortable and capable assessing suicide risk

A virtual patient named Denise may help future physicians feel more comfortable and capable assessing suicide risk.

7 Jan 2013

Brain structure linked to neuropsychopathology in psychosis patients

Results from an Italian study show that the structural development of key brain regions is associated with neuropsychopathology in patients with first-episode schizophrenia.

19 Dec 2012

Default mode network impaired in young adults at risk for psychosis

Young adults at genetic risk for psychosis show reduced activity in the default mode network area of the brain compared with those without such a family history, researchers report.

18 Dec 2012

Physicians should not prescribe cognitive enhancers to healthy people

Physicians should not prescribe cognitive enhancers to healthy individuals, states a report being published today in the Canadian Medical Association Journal (CMAJ).

18 Dec 2012

Schizophrenia tends to be elevated in more urban communities: Study

Higher rates of schizophrenia in urban areas can be attributed to increased deprivation, increased population density and an increase in inequality within a neighbourhood, new research reveals.

15 Dec 2012

Diabetes risk increased in relatives of schizophrenia patients

The prevalence of diabetes is increased in the unaffected relatives of patients with non-affective psychosis, results from a Dutch study show.

14 Dec 2012

Fatal imbalance between global disease burden and drug development

Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/M-decins Sans Fronti-res (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.

13 Dec 2012

Cognitive remediation may benefit youth with psychosis

Results from a Swiss study suggest that computer-assisted cognitive remediation may help improve certain aspects of cognition in adolescent patients with or at risk for psychosis.

11 Dec 2012

Depression, anxiety not linked to psychosis transition

Depression and anxiety disorders are common in patients at increased clinical risk for psychosis, but do not appear to influence transition to full-blown psychosis, say UK researchers.

5 Dec 2012